No Patient Left Behind: Connecting Rare Disease Patients to Orphan Drug Manufacturers

No Patient Left Behind: Connecting Rare Disease Patients to Orphan Drug Manufacturers

Released Wednesday, 27th July 2016
Good episode? Give it some love!
No Patient Left Behind: Connecting Rare Disease Patients to Orphan Drug Manufacturers

No Patient Left Behind: Connecting Rare Disease Patients to Orphan Drug Manufacturers

No Patient Left Behind: Connecting Rare Disease Patients to Orphan Drug Manufacturers

No Patient Left Behind: Connecting Rare Disease Patients to Orphan Drug Manufacturers

Wednesday, 27th July 2016
Good episode? Give it some love!
Rate Episode

Marc Iskowitz, MM&M's editor in chief, discusses a qualitative/quantitative approach to meeting orphan drug marketers' engagement challenge with Michael Carlin, vice president at TrialCard.

Show More
Rate

Join Podchaser to...

  • Rate podcasts and episodes
  • Follow podcasts and creators
  • Create podcast and episode lists
  • & much more

Episode Tags

Do you host or manage this podcast?
Claim and edit this page to your liking.
,

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features